Miflasone (Beclometasone Dipropionate)

Beclometasone dipropionate, the active ingredient in Miflasone, is a corticosteroid presented as an inhalation formulation for inhalation use. It treats asthma and chronic obstructive pulmonary disease (COPD) in adults and children by reducing airway inflammation and hyper‑responsiveness. It is indicated for maintenance therapy and can be used as part of a step‑wise treatment plan.

GNH USA supplies Miflasone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics.

Miflasone, a corticosteroid inhaler, acts on airway inflammation in respiratory disease.

Asthma: reduces airway inflammation, improves lung function and decreases frequency of symptoms. COPD: decreases exacerbations, improves airflow and helps control chronic symptoms. Exercise‑induced bronchoconstriction: provides prophylactic anti‑inflammatory control to prevent airway narrowing during physical activity.

Beclometasone dipropionate may cause local and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Oral thrush (candidiasis): fungal infection of the mouth. - Hoarseness or dysphonia: voice changes due to laryngeal irritation. - Cough or throat irritation: mild respiratory discomfort. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Adrenal suppression: reduced cortisol production with systemic exposure. - Pneumonia: increased risk of lower respiratory tract infection. - Paradoxical bronchospasm: sudden worsening of airway obstruction after inhalation.

When prescribing Miflasone, clinicians should observe the following precautions to ensure safe use. - Assess infection risk: avoid use during active respiratory infections. - Monitor growth in children: long‑term therapy may affect growth velocity. - Ensure proper inhalation technique: use spacer and rinse mouth to reduce local effects. - Avoid abrupt discontinuation: taper dosage if used for extended periods. - Review concomitant steroids: cumulative systemic exposure may increase side‑effects. - Store at room temperature: keep device in original packaging, protect from moisture and heat.

Beclometasone dipropionate can interact with other medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic corticosteroid levels. - Live vaccines: risk of systemic immunosuppression and reduced vaccine efficacy. - Concurrent use of multiple inhaled corticosteroids: risk of overdose and systemic effects.

Moderate Interactions (Monitor Closely): - Systemic corticosteroids: additive immunosuppressive effects. - β2‑agonists: may mask worsening asthma symptoms. - Diuretics: potential for hypokalemia when combined with systemic exposure.